That downhill slide is reflected in feedback from disgruntled BlinkRx buyers in all kinds of other sites. On copyright, in which the assessments are fairly evenly break up at 45% 5-stars and 39% one-star (using an alert from copyright expressing that the pharmacy might be stacking the deck with "unsupported invitation solutions”), you'll see comm